Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1

被引:2138
作者
Ceradini, DJ [1 ]
Kulkarni, AR [1 ]
Callaghan, MJ [1 ]
Tepper, OM [1 ]
Bastidas, N [1 ]
Kleinman, ME [1 ]
Capla, JM [1 ]
Galiano, RD [1 ]
Levine, JP [1 ]
Gurtner, GC [1 ]
机构
[1] NYU, Sch Med, Inst Reconstruct Plast Surg, Lab Microvasc Res & Vasc Tissue Engn, New York, NY 10016 USA
关键词
D O I
10.1038/nm1075
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The trafficking of circulating stem and progenitor cells to areas of tissue damage is poorly understood. The chemokine stromal cell - derived factor-1 (SDF-1 or CXCL12) mediates homing of stem cells to bone marrow by binding to CXCR4 on circulating cells(1,2). SDF-1 and CXCR4 are expressed in complementary patterns during embryonic organogenesis and guide primordial stem cells to sites of rapid vascular expansion(3). However, the regulation of SDF-1 and its physiological role in peripheral tissue repair remain incompletely understood(4). Here we show that SDF-1 gene expression is regulated by the transcription factor hypoxia-inducible factor-1 (HIF-1) in endothelial cells, resulting in selective in vivo expression of SDF-1 in ischemic tissue in direct proportion to reduced oxygen tension. HIF-1-induced SDF-1 expression increases the adhesion, migration and homing of circulating CXCR4-positive progenitor cells to ischemic tissue. Blockade of SDF-1 in ischemic tissue or CXCR4 on circulating cells prevents progenitor cell recruitment to sites of injury. Discrete regions of hypoxia in the bone marrow compartment also show increased SDF-1 expression and progenitor cell tropism. These data show that the recruitment of CXCR4-positive progenitor cells to regenerating tissues is mediated by hypoxic gradients via HIF-1-induced expression of SDF-1.
引用
收藏
页码:858 / 864
页数:7
相关论文
共 30 条
[1]   Stromal cell-derived factor-1α associates with heparan sulfates through the first β-strand of the chemokine [J].
Amara, A ;
Lorthioir, O ;
Valenzuela, A ;
Magerus, A ;
Thelen, M ;
Montes, M ;
Virelizier, JL ;
Delepierre, M ;
Baleux, F ;
Lortat-Jacob, H ;
Arenzana-Seisdedos, F .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (34) :23916-23925
[2]   Isolation of putative progenitor endothelial cells for angiogenesis [J].
Asahara, T ;
Murohara, T ;
Sullivan, A ;
Silver, M ;
vanderZee, R ;
Li, T ;
Witzenbichler, B ;
Schatteman, G ;
Isner, JM .
SCIENCE, 1997, 275 (5302) :964-967
[3]   Effect of stromal-cell-derived factor 1 on stem-cell homing and tissue regeneration in ischaemic cardiomyopathy [J].
Askari, AT ;
Unzek, S ;
Popovic, ZB ;
Goldman, CK ;
Forudi, F ;
Kiedrowski, M ;
Rovner, A ;
Ellis, SG ;
Thomas, JD ;
DiCorleto, PE ;
Topol, EJ ;
Penn, MS .
LANCET, 2003, 362 (9385) :697-703
[4]   Chemokines and the arrest of lymphocytes rolling under flow conditions [J].
Campbell, JJ ;
Hedrick, J ;
Zlotnik, A ;
Siani, MA ;
Thompson, DA ;
Butcher, EC .
SCIENCE, 1998, 279 (5349) :381-384
[5]   HMG-CoA reductase inhibitors (statins) increase endothelial progenitor cells via the PI 3-kinase/Akt pathway [J].
Dimmeler, S ;
Aicher, A ;
Vasa, M ;
Mildner-Rihm, C ;
Adler, K ;
Tiemann, M ;
Rütten, H ;
Fichtlscherer, S ;
Martin, H ;
Zeiher, AM .
JOURNAL OF CLINICAL INVESTIGATION, 2001, 108 (03) :391-397
[6]   Induction of hypervascularity without leakage or inflammation in transgenic mice overexpressing hypoxia-inducible factor-1α [J].
Elson, DA ;
Thurston, G ;
Huang, LE ;
Ginzinger, DG ;
McDonald, DM ;
Johnson, RS ;
Arbeit, JM .
GENES & DEVELOPMENT, 2001, 15 (19) :2520-2532
[7]  
Forsythe JA, 1996, MOL CELL BIOL, V16, P4604
[8]   Oxygen saturation in the bone marrow of healthy volunteers [J].
Harrison, JS ;
Rameshwar, P ;
Chang, V ;
Bandari, P .
BLOOD, 2002, 99 (01) :394-394
[9]   Plasma elevation of stromal cell-derived factor-1 induces mobilization of mature and immature hematopoietic progenitor and stem cells [J].
Hattori, K ;
Heissig, B ;
Tashiro, K ;
Honjo, T ;
Tateno, M ;
Shieh, JH ;
Hackett, NR ;
Quitoriano, MS ;
Crystal, RG ;
Rafii, S ;
Moore, MAS .
BLOOD, 2001, 97 (11) :3354-3360
[10]   Circulating endothelial progenitor cells, vascular function, and cardiovascular risk [J].
Hill, JM ;
Zalos, G ;
Halcox, JPJ ;
Schenke, WH ;
Waclawiw, MA ;
Quyyumi, AA ;
Finkel, T .
NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (07) :593-600